Balyasny Asset Management LLC Reata Pharmaceuticals Inc Call Options Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $8.79 Million - $17 Million	-112,300 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $10.6 Million - $14.9 Million	112,300 New	112,300 $11.2 Million
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $7.14 Million - $12.9 Million	-70,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $6.55 Million - $11.4 Million	70,000 New	70,000 $6.82 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $1.26 Million - $1.77 Million	-10,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $1.24 Million - $2.48 Million	10,000 New	10,000 $1.44 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.